The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Open accessThe DOI matches its Crossref record; 251 of the 253 references it cites were found in a registry or an index.
Abstract
For years, it has been reported that Alzheimer’s disease (AD) is the most common cause of dementia. Various external and internal factors may contribute to the early onset of AD. This review highlights a contribution of the disturbances in the microbiota–gut–brain (MGB) axis to the development of AD. Alteration in the gut microbiota composition is determined by increase in the permeability of the gut barrier and immune cell activation, leading to impairment in the blood–brain barrier function that promotes neuroinflammation, neuronal loss, neural injury, and ultimately AD. Numerous studies have shown that the gut microbiota plays a crucial role in brain function and changes in the behavior of individuals and the formation of bacterial amyloids. Lipopolysaccharides and bacterial amyloids synthesized by the gut microbiota can trigger the immune cells residing in the brain and can activate the immune response leading to neuroinflammation. Growing experimental and clinical data indicate the prominent role of gut dysbiosis and microbiota–host interactions in AD. Modulation of the gut microbiota with antibiotics or probiotic supplementation may create new preventive and therapeutic options in AD. Accumulating evidences affirm that research on MGB involvement in AD is necessary for new treatment targets and therapies for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This process is accompanied by imbalanced neurotransmission,218 which ultimately leads to neuronal degeneration and damage.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [218]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 1×
“The immune system modulates the gut microbiota framework and issuance [171], while in return, the microbial symbionts control immune system maturation and function [172,173].”
BackgroundAFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,149 · cited 1×
“Probiotics are defined as living microbial feed supplements which show a beneficial effect on the host, resulting in improved intestinal microbial balance [230].”
BackgroundHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · cited 2×
“SCFA claimed to reestablish microglial density and normalized CSF1R surface expression [203].”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“The individuals in the nursing home had less microbiota attributed to a limited diet [59].”
BackgroundGut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001 · cited 9×
“Claims on the potential involvement of the gut microbiota in brain function are made, in part, due to the well-described pathways of communication between the brain and the GIT which has been intensively studied in the area of food intake, satiety, and regulation of the digestive tract [109].”
BackgroundInfluentialDietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Gut microbiota functions: metabolism of nutrients and other food components
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1445-8 · Cited by 2,878 · cited 1×
“These findings suggest that the microbiota performs numerous vital functions in our body, including releasing biochemical by-products such as SCFA and gases [88].”
BackgroundDel Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023) · Inflammation · doi:10.1007/s10753-022-01721-1 · Cited by 557
“The pro-inflammatory cytokines then produced cause disturbance in blood–brain barrier permeability which facilitates the bacterial metabolite to reach inside the brain and drive pathological conditions related to AD [46].”
BackgroundPathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
“The gut microbiota framework influences brain function and the gut-brain connection by producing different neurotransmitters and neuro-modulators (Megur et al., 2020).”
BackgroundThe promotion mechanism of prebiotics for probiotics: A review
You, S., Ma, Y., Yan, B., Pei, W., Wu, Q., Ding, C., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1000517 · Cited by 295
Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278
Sun, J., Zhang, Y., Kong, Y., Ye, T., Yu, Q., Kumaran Satyanarayanan, S., Su, K.-P., & Liu, J. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.08.003 · Cited by 255
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 202
Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Yu, T.-W., Lane, H.-Y., & Lin, C.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158208 · Cited by 176
Kearns, R. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01496-z · Cited by 191
“Neuroinflammation mediated by the KP is implicated in the pathogenesis of various neurological disorders, including depression, Alzheimer’s disease, and Parkinson’s disease (Bay-Richter & Wegener 2022; Megur et al. 2021; Venkatesan et al. 2020).”
BackgroundDoroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 175
The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
Liu, Y., Tan, Y., Zhang, Z., Yi, M., Zhu, L., & Peng, W. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00397-x · Cited by 174
“The composition of intestinal microbes can be influenced by the increased intestinal barrier permeability and immune cell activation [241].”
BackgroundMegur, A., Daliri, E. B., Baltriukienė, D., & Burokas, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116097 · Cited by 167
“GM makes a crucial contribution to the production of enzymes that are not encoded by the human genome, for example, the breakdown of polysaccharides, polyphenols, and the synthesis of vitamins [12]; is pivotal for human development and physiology [13]; and plays a vital role in regulatory functions in health and disea…”
BackgroundSelf-citationEicher, T. P., & Mohajeri, M. H. (2022) · Nutrients · doi:10.3390/nu14132661 · Cited by 142
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
Barros, G., Durán, P., Vera, I., & Bermúdez, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147499 · Cited by 151
“This fact reveals a more complex system, the Microbiota-immune-adipose-neuroendocrine axis, on which alterations such as beta-cell apoptosis [26], fatty acid liver disease (and subsequent liver cirrhosis) [27], neuroinflammation with cognitive impairment [28], dysfunctional adipose tissue [29] (due to hypoxia and Endo…”
BackgroundGao, L., Jin, L., Liu, Q., Zhao, K., Lin, L., Zheng, J., Li, C., Chen, B., & Shen, Y. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104211 · Cited by 118
Basiouni, S., Téllez‐Isaías, G., Latorre, J. D., Graham, D. B., Petrone-García, V. M., El-Seedi, H. R., Yalçın, S., El‐Wahab, A. A., Visscher, C., May‐Simera, H., et al. (2023) · Veterinary Sciences · doi:10.3390/vetsci10010055 · Cited by 132
Bile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease
Mulak, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210608 · Cited by 114
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Sharma, V., Singh, T. G., Garg, N., Dhiman, S., Gupta, S., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M. S., Albadrani, G. M., et al. (2021) · Biomolecules · doi:10.3390/biom11050678 · Cited by 117
Yang, L., Wang, Y., Li, Z., Wu, X., Mei, J., & Zheng, G. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120714 · Cited by 110
Das, T. K., & Ganesh, B. P. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2206504 · Cited by 109
Phytogenic feed additives as alternatives to antibiotics in poultry production: A review
Aminullah, N., Mostamand, A., Zahir, A., Mahaq, O., & Azizi, M. N. (2025) · Veterinary World · doi:10.14202/vetworld.2025.141-154 · Cited by 104
“Poultry gut health is directly linked to its microbiota balance, which can directly affect intestinal lining health, biological activities, and nutrient absorption, leading to impacts on systemic immunity, neuroendocrine activity, and productivity [6, 42].”
Melrose, J. (2023) · Antioxidants · doi:10.3390/antiox12030663 · Cited by 106
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 96
“…the blood and oral cavity microbiomes) may play a role in the risk to develop age-related neurodegenerative diseases, including AD and PD (Kell and Pretorius, 2018; Megur et al., 2020; Potgieter et al., 2015; Pritchard et al., 2017; Sochocka et al., 2018; Ticinesi et al., 2018; Vogt et al., 2017).”
BackgroundSoldán, M., Argalášová, Ľ., Hadvinová, L., Galileo, B., & Babjaková, J. (2024) · Nutrients · doi:10.3390/nu16183134 · Cited by 101
Sheng, C., Yang, K. Y., He, B., Du, W., Cai, Y., & Han, Y. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00977-x · Cited by 93
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Toledo, A. R. L., Monroy, G. R., Salazar, F. E., Lee, J.-Y., Jain, S., Yadav, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031184 · Cited by 93
“Indeed, dampening the pro-inflammatory immune response product of pathogenic bacteria secretions and natural immune response in the gut affords therapeutic effects in NDDs [11].”
BackgroundStress and the gut-brain axis: an inflammatory perspective
Morys, J., Małecki, A., & Nowacka-Chmielewska, M. M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1415567 · Cited by 94
The Role of Gut Microbiome in Sleep Quality and Health: Dietary Strategies for Microbiota Support
Sejbuk, M., Siebieszuk, A., & Witkowska, A. M. (2024) · Nutrients · doi:10.3390/nu16142259 · Cited by 92
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 82
Liang, L., Saunders, C., & Sanossian, N. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3229 · Cited by 85
Altered gut microbiota in adults with subjective cognitive decline: the SILCODE study
Sheng, C., Lin, L., Lin, H., Wang, X., Han, Y., & Liu, S.-L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210259 · Cited by 78
Liang, Y., Liu, C., Cheng, M., Geng, L., Li, J., Du, W., Song, M., Chen, N., Yeleen, T. A. N., Li, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14057 · Cited by 83
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis
Belelli, D., Lambert, J. J., Wan, M. L. Y., Monteiro, A. R., Nutt, D. J., & Swinny, J. D. (2024) · Brain · doi:10.1093/brain/awae413 · Cited by 83
“168,169 Next, we focus specifically on the emerging evidence regarding mood disorders.”
Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., Gong, X., Cui, M., Li, X., & Tang, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382223 · Cited by 83
“Additionally, subsequent studies found that the neuroinflammation mediated by NACHT-leucine-rich repeat and pyrin domain-containing protein 3 was aggravated by the presence of chronic colitis (Marogianni et al., 2020; Megur et al., 2020).”
BackgroundImplications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease
Bello-Corral, L., Gomes, L., Fernández-Fernández, J. A., Fernández-García, D., Verdejo, I. C., & Sánchez-Valdeón, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122132 · Cited by 79
“This axis involves other systems such as the autonomic nervous system, the endocrine system, the hypothalamic – pituitary – adrenal axis, the immune system and the microbiota and its metabolites [13,14].”
Short-chain fatty acids: Important components of the gut-brain axis against AD
Huang, Y., Wang, Y. F., Miao, J., Zheng, R. F., & Li, J. Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116601 · Cited by 70
Krishaa, L., Ng, T. K. S., Wee, H. N., & Ching, J. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111787 · Cited by 73
“leading to neuroinflammatory response and neurodegeneration (Megur et al., 2020).”
BackgroundInfluentialPsychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?
Binda, S., Tremblay, A., Iqbal, U., Kassem, O., Barz, M. L., Thomas, V., Bronner, S., Perrot, T. S., Ismail, N., & Parker, J. A. (2024) · Microorganisms · doi:10.3390/microorganisms12040634 · Cited by 68
Fang, X., Yue, M., Wei, J., Wang, Y., Hong, D., Wang, B., Zhou, X., & Chen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792746 · Cited by 64
Neutrophils as a potential therapeutic target in Alzheimer’s disease
Aries, M. L., & Hensley‐McBain, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123149 · Cited by 68
Merino, M., Clemente‐Suárez, V. J., Ruisoto, P., Jiménez, M., Ramos‐Campo, D. J., Beltrán-Velasco, A. I., Martínez‐Guardado, I., Rubio-Zarapuz, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2024) · Metabolites · doi:10.3390/metabo14100549 · Cited by 69
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R.-L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011272 · Cited by 63
Megur, A., Daliri, E. B., Balnionytė, T., Stankevičiūtė, J., Lastauskienė, E., & Burokas, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1213370 · Cited by 62
Self-citationGut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment
Zou, X., Zou, G., Zou, X., Wang, K., & Chen, Z. (2024) · PeerJ · doi:10.7717/peerj.17061 · Cited by 53
Ruiz‐González, C., Cardona, D., Rueda‐Ruzafa, L., Rodríguez-Arrastia, M. J., Ropero‐Padilla, C., & Román, P. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10315-2 · Cited by 58
“…(GBA) [8] as a bidirectional communication pathway between the gastrointestinal tract and the brain has made it possible to link disorders of the GM with neurodegenerative pathologies such as Alzheimer’s (AD) and Parkinson’s disease (PD) or mood disorders including anxiety and depression [9–11].”
The gut microbiota in retinal diseases
Bringer, M.-A., Gabrielle, P., Bron, A. M., Creuzot-Garcher, C. P., & Acar, N. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108867 · Cited by 53
“In humans, dysbiosis has been linked to inflammation in numerous pathological conditions such as inflammatory bowel diseases, metabolic disorders, and some age-related neuroinflammatory diseases, including Alzheimer’s disease (Megur et al., 2020; Neurath, 2020; Tilg et al., 2020).”
BackgroundInflammatory bowel disease: A potential pathogenic factor of Alzheimer's disease
Wang, D., Zhang, X., & Du, H. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110610 · Cited by 57
Wadan, A.-H. S., El‐Aziz, M. K. A., & Ellakwa, D. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04155-2 · Cited by 60
“Firstly, heterogeneity in study designs—including differences in probiotic strains, dosages, and treatment durations—hinders the ability to draw definitive conclusions regarding their efficacy (Megur et al. 2020).”
Huang, J., Wei, S., Jiang, C., Xiao, Z., Liu, J., Peng, W., Zhang, B., & Li, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.808837 · Cited by 58
Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease
D’Argenio, V., Veneruso, I., Gong, C., Cecarini, V., Bonfili, L., & Eleuteri, A. M. (2022) · Genes · doi:10.3390/genes13091564 · Cited by 50
Kyei-Baffour, V. O., Vijaya, A. K., Burokas, A., & Daliri, E. B. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2459341 · Cited by 58
Self-citationThe Kynurenine Pathway in Gut Permeability and Inflammation
Kearns, R. (2024) · Inflammation · doi:10.1007/s10753-024-02135-x · Cited by 54
“Neuroinflammation mediated by the kynurenine pathway is implicated in the pathogenesis of various neurological disorders, including depression, Alzheimer's disease, and Parkinson's disease [6, 79, 115].”
Iqbal, N. T., Khan, H., Khalid, A., Mahmood, S. F., Nasir, N., Khanum, I., de Siqueira, I. C., & Voorhis, W. C. V. (2025) · Molecular Medicine · doi:10.1186/s10020-024-00986-6 · Cited by 54
“Moreover, it may also be linked with cognitive and neurodegenerative disorders such as autism spectrum disorder (ASD) (Yu and Zhao 2021), Parkinson’s, (Klann et al. 2021) and Alzheimer disease (Megur et al. 2020).”
Post-traumatic Stress Disorder: Focus on Neuroinflammation
Li, J., Tong, L., Schock, B. C., & Ji, L.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03320-z · Cited by 51
Alzheimer’s Disease: A Systems View Provides a Unifying Explanation of Its Development
Grobler, C., van Tongeren, M., Gettemans, J., Kell, D. B., & Pretorius, E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220720 · Cited by 50
New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
Doroszkiewicz, J., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168902 · Cited by 50
He, C., Jiang, J., Liu, J., Zhou, L., Ge, Y., & Yang, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132372 · Cited by 49
Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles
Zhou, W., Zhao, L., Mao, Z., Wang, Z., Zhang, Z., & Li, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01345-5 · Cited by 46
“Disturbances in the gut microenvironment are associated with AD (Kesika et al. 2021; Megur et al. 2020), spectrum disorders (Socala et al. 2021; Srikantha & Mohajeri 2019), and PD (Mulak & Bonaz 2015; Sampson et al. 2016).”
BackgroundProgress on early diagnosing Alzheimer’s disease
Chen, Y., Al‐Nusaif, M., Li, S., Tan, X., Yang, H., Cai, H., & Le, W. (2024) · Frontiers of Medicine · doi:10.1007/s11684-023-1047-1 · Cited by 46
Soriano, S., Curry, K. D., Wang, Q., Chow, E., Treangen, T. J., & Villapol, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094476 · Cited by 44
“Similarly, the production of amyloid by bacteria or fungi in the gut microbiota may induce neurodegeneration and inflammation [48,49].”
BackgroundAlzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
Hu, J., & Wang, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.811852 · Cited by 49
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Saleh, M., Marković, M., Olson, K. E., Gendelman, H. E., & Mosley, R. L. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223278 · Cited by 44
Acupuncture treatment for post-stroke depression: Intestinal microbiota and its role
Jiang, H., Deng, S., Zhang, J., Chen, J., Li, B., Zhu, W., Zhang, M., Zhang, C., & Meng, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1146946 · Cited by 44
“…intestinal peptide (VIP), and some neurotransmitter precursors (e.g., 5-HTP) were more readily transported across the BBB to the brain due to increased BBB permeability (Birdsall, 1998; Dogrukol-Ak et al., 2003; Nedorubov et al., 2019; Megur et al., 2020; Formolo et al., 2022; Zhao et al., 2022).”
BackgroundWu, M., Cheng, Y., Zhang, R., Han, W., Jiang, H., Bi, C., Zhang, Z., Ye, M., Lin, X., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117228 · Cited by 41
Dietary polyphenols maintain human health through modulation of gut microbiota
Rudrapal, M., de Oliveira, A. M., & Singh, R. P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1710088 · Cited by 44
Huston, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.904107 · Cited by 42
Liu, H., Gao, C., Xu, Y., Fang, Q., Ye, L., Wang, C., & Liu, X. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.852269 · Cited by 42
Yang, J., Wang, L., Liu, H., Xu, H., Liu, F., Song, H., Zhao, X., & Li, H. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106272 · Cited by 38
Pan, Z., Wu, N., & Jin, C. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3080969 · Cited by 42
The critical role of gut-brain axis microbiome in mental disorders
Basiji, K., Sendani, A. A., Ghavami, S. B., Farmani, M., Kazemifard, N., Sadeghi, A., Lotfali, E., & Aghdaei, H. A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01248-w · Cited by 58
“The Role of gut-microbiota in Alzheimer’s disease evidence shows that gut microbiota implicates in lots of neurodegenerative diseases including AD and plays a cru - cial role in brain functions and causes behavior alteration (Doifode et al. 2021; Megur et al. 2021).”
BackgroundJamerlan, A., An, S. S. A., & Hulme, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486518 · Cited by 40
“100 The MGBA plays a crucial role in this process, 14–16 with the gut microbiota influencing brain function through specific metabolites.”
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 35
Li, X., Ding, Q., Wan, X., Wu, Q., Ye, S., & Lou, Y. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00265-8 · Cited by 35
Liu, P., Zhou, X., Zhang, H., Wang, R., Wu, X., Jian, W., Li, W., Yuan, D., Wang, Q., & Zhao, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796542 · Cited by 35
Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Das, T. K., Ganesh, B. P., & Fatima-Shad, K. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220108 · Cited by 35
[Retracted] A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction‐Related Diseases
Weng, Z.-B., Chen, Y.-R., Lv, J.-T., Wang, M.-X., Chen, Z.-Y., Zhou, W., Shen, X.-C., Zhan, L.-B., & Wang, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4289383 · Cited by 32
RetractedTherapeutic Effects of Baicalin on Diseases Related to Gut–Brain Axis Dysfunctions
Hu, Q., Hou, S., Xiong, B., Wen, Y., Wang, J., Zeng, J., Ma, X., & Wang, F. (2023) · Molecules · doi:10.3390/molecules28186501 · Cited by 33
Taiwanese Vegetarians Are Associated with Lower Dementia Risk: A Prospective Cohort Study
Tsai, J., Huang, C.-F., Lin, M., Chang, C.-E., Chang, C.-C., & Lin, C.-L. (2022) · Nutrients · doi:10.3390/nu14030588 · Cited by 32
“GM dysbiosis plays an important role in the development of AD, by causing amyloid-beta aggregation and neuroinflammation [30,31].”
BackgroundExploring the Role of Microglial Cells in the Gut–Brain Axis Communication: A Systematic Review
Ortiz‐Samur, N. S., Vijaya, A. K., Burokas, A., & Mela, V. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70154 · Cited by 31
“…in neurodegenerative disease models, where the administration of beneficial bacterial strains such as Blautia producta , some of Lactobacillus and Bifidobacterium strains, restores homeostatic microglial function and attenuates neuroinflammatory responses (Liu et al. 2024; Megur et al. 2020).”
Self-citationZhan, Y., Al‐Nusaif, M., Ding, C., Zhao, L., & Dong, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1130730 · Cited by 34
Urolithins: A Prospective Alternative against Brain Aging
An, L., Lu, Q., Wang, K., & Wang, Y. (2023) · Nutrients · doi:10.3390/nu15183884 · Cited by 31
Cao, B., Zeng, M., Hao, F.-X., Hao, Z., Zhang, Z.-K., Liang, X.-W., Wu, Y., Zhang, Y., Feng, W., & Zheng, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115825 · Cited by 30
Yan, X., Shi, L., Zhu, X.-L., Zhao, Y., Luo, J., Li, Q., Xu, Z., & Zhao, J. J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s531671 · Cited by 31
“29 Notably, intracerebral LPS administration in mouse models has been associated with elevated amyloid-beta (Aβ) levels in the hippocampus, correlating with cognitive deficits.”
Intestinal microbiota: A promising therapeutic target for hypertension
Sun, D., Xiang, H., Yan, J., & He, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.970036 · Cited by 31
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 33
“On the other hand, GM can trigger a cytokine storm that causes abnormal accumulation of pathogenic proteins in the brain by causing an excessive inflammatory response in the body (Megur et al., 2020).”
BackgroundParasite infections, neuroinflammation, and potential contributions of gut microbiota
Alloo, J., Leleu, I., Grangette, C., & Pied, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1024998 · Cited by 31
“This defect of the GM is associated with changes in microglial mRNA profiles in the germ-free mice: genes involved in cell activation, pathogen recognition, and host defense were downregulated in the animals’ microglia, whereas genes encoding survival factors (which are usually suppressed in conventional animals) were…”
BackgroundRiehl, L., Fürst, J., Kress, M., & Rykalo, N. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1302957 · Cited by 31
Lai, Z., Ke, L. W., & Zhao, W. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1647967 · Cited by 29
Téllez‐Isaías, G., Eisenreich, W., Petrone-García, V. M., Hernández-Velasco, X., Castellanos-Huerta, C.-H., Téllez‐Isaías, G., Latorre, J. D., Bottje, W. G., Señas-Cuesta, R., Coles, M. E., et al. (2023) · German Journal of Veterinary Research · doi:10.51585/gjvr.2023.1.0051 · Cited by 32
Yeo-Teh, N. S. L., & Tang, B. L. (2023) · Science and Engineering Ethics · doi:10.1007/s11948-022-00422-0 · Cited by 28
Chakraborty, P., Banerjee, D., Majumder, P., & Sarkar, J. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100104 · Cited by 29
Ren, J., Wang, Q., Hong, H., & Tang, C. (2025) · Microorganisms · doi:10.3390/microorganisms13081956 · Cited by 30
“Recent breakthroughs in microbiome research have unveiled the gut microbiota (GM) as a critical regulator of neurological health through the microbiota–gut–brain axis (MGBA) [7].”
The molecular signaling of exercise and obesity in the microbiota-gut-brain axis
Ribeiro, F. M., Silva, M. A., Lyssa, V., Marques, G., Lima, H. K., Franco, O. L., & Petriz, B. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927170 · Cited by 30
Xiang, Q., Liu, Y., Wu, Z., Wang, R., & Zhang, X. (2023) · Food Frontiers · doi:10.1002/fft2.199 · Cited by 27
Correlation between Alzheimer’s Disease and Gastrointestinal Tract Disorders
Kuźniar, J., Kozubek, P., Czaja, M., & Leszek, J. (2024) · Nutrients · doi:10.3390/nu16142366 · Cited by 27
Brain-Gut and Microbiota-Gut-Brain Communication in Type-2 Diabetes Linked Alzheimer’s Disease
Momen, Y. S., Mishra, J., & Kumar, N. (2024) · Nutrients · doi:10.3390/nu16152558 · Cited by 29
“LPS can activate the TLRs expressed on microglia, which are resident macrophages in the brain and are considered a key player in neuroinflammation [155].”
Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 31
“In PD, this dysbiosis significantly affects the gut-brain communication network, also known as the microbiota-gut-brain axis (MGBA) [21, 29].”
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Lewis, N., Villani, A., & Lagopoulos, J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.031 · Cited by 25
Gut-brain relationship in dementia and Alzheimer's disease: Impact on stress and immunity
Mukherjee, U., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102843 · Cited by 28
Metadata
- Authors
- Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A.
- Affiliations
- Vilnius University (LT)
- Corresponding author
- Burokas, Aurelijus
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-24
- Volume
- 13
- Issue
- 1
- Pages
- 37
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7824474
- OpenAlex
- W3115136688
- Cited by
- 323
- References
- 253
- Citations by year
- 2026: 44 · 2025: 75 · 2024: 75 · 2023: 54 · 2022: 57 · 2021: 18
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The European Regional Development Fund under grant agreement with the Research Council of Lithuania (LMTLT) (01.2.2-LMT-K-718-02-0014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, microbiota-gut-brain axis, gut dysbiosis, neuroinflammation, blood-brain barrier, intestinal permeability, lipopolysaccharide, bacterial amyloids, probiotics, antibiotics, dementia
- MeSH terms
- Gastrointestinal Microbiome, Alzheimer Disease, Animals, Anti-Bacterial Agents, Brain, Encephalitis, Humans, Intestines, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.